AstraZeneca Pharma India Balance Sheet Health
Financial Health criteria checks 5/6
AstraZeneca Pharma India has a total shareholder equity of ₹6.5B and total debt of ₹53.5M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are ₹11.0B and ₹4.5B respectively. AstraZeneca Pharma India's EBIT is ₹1.8B making its interest coverage ratio -8.2. It has cash and short-term investments of ₹5.2B.
Key information
0.8%
Debt to equity ratio
₹53.48m
Debt
| Interest coverage ratio | -8.2x |
| Cash | ₹5.20b |
| Equity | ₹6.55b |
| Total liabilities | ₹4.47b |
| Total assets | ₹11.02b |
Recent financial health updates
No updates
Recent updates
We Ran A Stock Scan For Earnings Growth And AstraZeneca Pharma India (NSE:ASTRAZEN) Passed With Ease
Apr 04
Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?
Nov 10AstraZeneca Pharma India's (NSE:ASTRAZEN) Dividend Will Be Increased To ₹16.00
Jul 06Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?
Jun 16Increases to CEO Compensation Might Be Put On Hold For Now at AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
Aug 02Here's Why I Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is An Interesting Stock
Feb 25Could The AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Ownership Structure Tell Us Something Useful?
Feb 04Declining Stock and Solid Fundamentals: Is The Market Wrong About AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?
Jan 18
Announcing: AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Increased An Energizing 282% In The Last Five Years
Dec 31We're Not Counting On AstraZeneca Pharma India (NSE:ASTRAZEN) To Sustain Its Statutory Profitability
Dec 13Here's Why We Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is Well Worth Watching
Nov 25Here's What We Think About AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Pay
Nov 07What Kind Of Investors Own Most Of AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?
Oct 20AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Sep 24If You Had Bought AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Three Years Ago, You Could Pocket A 298% Gain Today
Aug 28What Did AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Take Home Last Year?
Aug 02Could The AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Ownership Structure Tell Us Something Useful?
Jul 12Financial Position Analysis
Short Term Liabilities: ASTRAZEN's short term assets (₹9.5B) exceed its short term liabilities (₹4.4B).
Long Term Liabilities: ASTRAZEN's short term assets (₹9.5B) exceed its long term liabilities (₹111.4M).
Debt to Equity History and Analysis
Debt Level: ASTRAZEN has more cash than its total debt.
Reducing Debt: ASTRAZEN's debt to equity ratio has increased from 0% to 0.8% over the past 5 years.
Debt Coverage: ASTRAZEN's debt is well covered by operating cash flow (1334.7%).
Interest Coverage: ASTRAZEN earns more interest than it pays, so coverage of interest payments is not a concern.